Jahāngīrpur (IN) Cancer Clinical Trials

Study Assessing the Efficacy and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced TNBC Who Carry Either a PIK3CA Mutation or Have PTEN Loss

~39 mi. (Faridabad, India, +170 more cities)

Novartis Investigative Site

ER Negative, +4 more biomarkers

Breast Carcinoma

alpelisib, +1 more drug

chemotherapy, +1 more type

A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer

~58 mi. (New Delhi, India, +192 more cities)

Maulana Azad Medical College

ER Positive, +1 more biomarker

Breast Carcinoma

abemaciclib, +1 more drug

hormone therapy, +1 more type

Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC

~58 mi. (New Delhi, India, +190 more cities)

Rajiv Gandhi Cancer Institute and Research Centre, +1 more facility

ATM Loss, +27 more biomarkers

Prostate Adenocarcinoma

enzalutamide, +1 more drug

hormone therapy, +1 more type

A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy

~58 mi. (New Delhi, India, +260 more cities)

Rajiv Gandhi Cancer Institute & Research Center

ERBB2 Amplification, +1 more biomarker

Invasive Breast Carcinoma

ado-trastuzumab emtansine, +1 more drug

immunotherapy, +1 more type

A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment

~58 mi. (New Delhi, India, +142 more cities)

Sir Ganga Ram Hospital, +1 more facility

del(11)(q10), +27 more biomarkers

Myelofibrosis

imetelstat, +1 more drug

targeted therapy

A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors

~58 mi. (New Delhi, India, +118 more cities)

All India Institute of Medical Sciences

NTRK1 Fusion, +2 more biomarkers

Biliary Tract Carcinoma, +12 more conditions

larotrectinib

targeted therapy

Study to Evaluate the Safety of Pembrolizumab in Participants With Unresectable or Metastatic Melanoma or Non-small Cell Lung Cancer in India (MK-3475-593/KEYNOTE-593)

~58 mi. (New Delhi, India, +5 more cities)

All India Institute of Medical Sciences ( Site 0012), +1 more facility

PD-L1 High Expression (TPS >= 50%), +1 more biomarker

Melanoma, +1 more condition

pembrolizumab

immunotherapy

To Study the Effects of Addition of Mebendazole to Lenvatinib in Cirrhotics With Advanced Hepatocellular Carcinoma.

~58 mi. (New Delhi, India)

Institute of Liver & Biliary Sciences

Hepatocellular Carcinoma

lenvatinib, +1 more drug

Other, +1 more type